CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
Jiyoul Yang, Ok-Jun Lee, Seung-Myoung Son, Chang Gok Woo, Yusook Jeong, Yaewon Yang, Jihyun Kwon, Ki Hyeong Lee, Hye Sook Han
Cancer Research and Treatment. 2018;50(3):908-916.   Published online 2017 September 19    DOI: https://doi.org/10.4143/crt.2017.378

Excel Download

EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
Cancer Research and Treatment. 2018;50(3):908-916   Crossref logo
Link1 Link2 Link3

Clinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations
OncoTargets and Therapy. 2017;Volume 10:3119-3122   Crossref logo
Link1 Link2

ID3021 Acquired resistance to with EGFR tyrosine kinase inhibitors by the EGFR T790M mutation in non-small cell lung cancer
Biomedical Research and Therapy. 2017;4(S):33   Crossref logo
Link1 Link2

PREVENTING AND TREATING BRAIN METASTASES WITH THREE FIRST-LINE EGFR-TYROSINE KINASE INHIBITORS IN PATIENTS WITH EGFR MUTATION-POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER
Respirology. 2018;23:285-285   Crossref logo
Link1 Link2

THE EGFR MUTATION PATTERN AFTER EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITORS THERAPY IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER HARBOURING ACTIVATING UNCOMMON EGFR MUTATIONS
Respirology. 2018;23:286-286   Crossref logo
Link1 Link2

Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non-T790M mutations after progression on first-line EGFR-tyrosine kinase inhibitors
Thoracic Cancer. 2018;9(9):1151-1155   Crossref logo
Link1 Link2

Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation
Journal of International Medical Research. 2014;42(5):1110-1117   Crossref logo
Link1 Link2 Link3

THE REAL-WORLD EFFICACY OF FIRST-LINE TYROSINE KINASE INHIBITORS IN ASIAN PATIENTS WITH EGFR MUTATION NON-SMALL CELL LUNG CANCER
Respirology. 2018;23:21-22   Crossref logo
Link1 Link2

EFFICACY OF 1ST/2ND-GENERATION EGFR-TKIS IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER (NSCLC) AND PLEURAL EFFUSION
Respirology. 2017;22:117-117   Crossref logo
Link1 Link2

Malignant Pleural Effusion Supernatants Are Substitutes for Metastatic Pleural Tumor Tissues in EGFR Mutation Test in Patients with Advanced Lung Adenocarcinoma
PLoS ONE. 2014;9(2):e89946   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.